Speakers

Stefanie Urlinger

Chief Scientific Officer • Cimeio Therapeutics

Stefanie Urlinger is Chief Scientific Officer at Cimeio Therapeutics, where she heads Research and Discovery. Stefanie has over 20 years of experience in large molecule engineering and development and has led antibody discovery efforts as well as the development of antibody platform technologies in different organizations, including MorphoSys, iOmx Therapeutics and Ridgeline Discovery. Stefanie has authored many scientific articles and is an inventor on over 60 granted patents. Stefanie earned her PhD from the Max-Planck-Institute for Biochemistry in Germany.

Also speaking

Image

Jessica Berlier

Director P&AD • Catalent Cell & Gene Therapy
10 August 2023
Image

Vera Araujo

Senior Director, Business Development • Andelyn Biosciences
10 July 2023
Image

David Del Bourgo

Chief Executive Officer • WhiteLab Genomics
17 August 2023

Event Info

Image

Sample Attendee List – 2024

Download and explore the 2024 Floorplan for Advanced Therapies Europe here.
3 December 2024
Image

Enquire to Sponsor/Exhibit

Take a look at the sample attendee list for Advanced Therapies Europe 2024 here.
27 November 2024